The ORCHESTRA trial explored whether adding tumor debulking to standard systemic therapy improves survival in metastatic colorectal cancer. With overall survival results pending, the researchers ...
CHICAGO — Tumor debulking does not improve survival in multiorgan metastatic colorectal cancer (CRC), according to a phase 3 trial presented at the American Society of Clinical Oncology (ASCO) 2024 ...
New research in the October 2023 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds that intensive local-regional treatment to remove as much tumor as possible (known as ...
Please provide your email address to receive an email when new articles are posted on . No statistically significant differences in health-related quality of life occurred with debulking plus systemic ...
Neoadjuvant chemotherapy with interval debulking surgery is associated with higher complete gross resection rates and lower postoperative mortality in advanced epithelial ovarian cancer. The use of ...
Overall survival (OS) in patients with platinum-sensitive relapsed ovarian cancer (PSROC) treated with olaparib maintenance monotherapy: Update from the L-MOCA trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results